{"result": {"id": "52792d01-e87d-4f74-b00f-d9fb662c5295", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>COX<|>ORGANIZATION<|>Cyclooxygenase, an enzyme inhibited by NSAIDs and aspirin, affecting cardiovascular protection and gastrointestinal bleeding risk>  \n##  \n(\"entity\"<|>CYP2C19<|>ORGANIZATION<|>Cytochrome P450 2C19, a liver enzyme involved in metabolizing drugs like clopidogrel, omeprazole, and esomeprazole>  \n##  \n(\"entity\"<|>CYP3A4<|>ORGANIZATION<|>Cytochrome P450 3A4, a liver enzyme that metabolizes many drugs, including some affected by strong inhibitors like posaconazole and clarithromycin>  \n##  \n(\"entity\"<|>泊沙康唑<|>ORGANIZATION<|>Posaconazole, a strong CYP3A4 inhibitor that can slow the metabolism of certain drugs>  \n##  \n(\"entity\"<|>伏立康唑<|>ORGANIZATION<|>Voriconazole, a strong CYP3A4 inhibitor that can slow the metabolism of certain drugs>  \n##  \n(\"entity\"<|>红霉素<|>ORGANIZATION<|>Erythromycin, a strong CYP3A4 inhibitor that can slow the metabolism of certain drugs>  \n##  \n(\"entity\"<|>克拉霉素<|>ORGANIZATION<|>Clarithromycin, a strong CYP3A4 inhibitor that can slow the metabolism of certain drugs>  \n##  \n(\"relationship\"<|>NSAID<|>COX<|>NSAIDs inhibit COX enzymes, reducing cardiovascular protection and increasing gastrointestinal bleeding risk<|>8>  \n##  \n(\"relationship\"<|>阿司匹林<|>COX<|>Aspirin inhibits COX enzymes, reducing cardiovascular protection and increasing gastrointestinal bleeding risk<|>8>  \n##  \n(\"relationship\"<|>氯吡格雷<|>CYP2C19<|>Clopidogrel's activation depends on CYP2C19 metabolism, which can be inhibited by omeprazole and esomeprazole<|>9>  \n##  \n(\"relationship\"<|>奥美拉唑<|>CYP2C19<|>Omeprazole competes with clopidogrel for CYP2C19 metabolism, reducing clopidogrel's efficacy<|>8>  \n##  \n(\"relationship\"<|>艾司奥美拉唑<|>CYP2C19<|>Esomeprazole competes with clopidogrel for CYP2C19 metabolism, reducing clopidogrel's efficacy<|>8>  \n##  \n(\"relationship\"<|>泊沙康唑<|>CYP3A4<|>Posaconazole is a strong inhibitor of CYP3A4, slowing the metabolism of certain drugs<|>7>  \n##  \n(\"relationship\"<|>伏立康唑<|>CYP3A4<|>Voriconazole is a strong inhibitor of CYP3A4, slowing the metabolism of certain drugs<|>7>  \n##  \n(\"relationship\"<|>红霉素<|>CYP3A4<|>Erythromycin is a strong inhibitor of CYP3A4, slowing the metabolism of certain drugs<|>7>  \n##  \n(\"relationship\"<|>克拉霉素<|>CYP3A4<|>Clarithromycin is a strong inhibitor of CYP3A4, slowing the metabolism of certain drugs<|>7>  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166573, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 763, "prompt_tokens": 3488, "total_tokens": 4251, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2880}, "prompt_cache_hit_tokens": 2880, "prompt_cache_miss_tokens": 608}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 心 血管保护作用，增 加消化道溃疡出血 风险\t参见说明书\t　NSAID 与阿司匹林抑制 COX，减弱心 血管保护功能，也增加了消化道溃疡 出血风险\t避免与布洛芬 等其他 NSAID 长期合用\n阿司匹林\t甲氨蝶呤\t增加毒性\t合用阿司匹林增加甲氨蝶呤血药浓 度，特别是大剂量（15 mg/ 周） 甲 氨蝶呤\t两药竞争肾脏排泄\t谨慎合用\n氯吡格雷\t奥美拉唑\t降低氯吡格雷疗效\t合用奥美拉唑使氯吡格雷活性代谢 物 H4 的 AUC0 → 24 h 减少\t　奥美拉唑与氯吡格雷竞争 CYP2C19 代 谢而影响了氯吡格雷的代谢活化\t避免合用\n氯吡格雷\t艾司奥美拉唑\t降低氯吡格雷疗效\t合用艾司奥美拉唑使氯吡格雷活性 代谢物 H4 的 AUC0 → 24 h 减少\t艾 司 奥 美 拉 唑 与 氯 吡 格 雷 竞 争 CYP2C19 代谢而影响了氯吡格雷的代 谢活化\t避免合用\n氯吡格雷\t雷贝拉唑\t-\t参见说明书；合用雷贝拉唑对氯吡 格雷活性代谢物 AUC0 → 24 h  的影响 轻微\t-\t可以合用\n注：INR= 国际标准化比值，NSAID= 非甾体类抗炎药，COX= 环氧合酶；- 为无此项\n表 6    治疗帕金森病药相关药物相互作用的潜在危害及处置\nTable 6     Potential risk and management of drug interactions in the treatment of Parkinson's disease\n药物名称\t联合药物\t临床后果\t药动学改变\t相互作用机制\t临床建议\n司来吉兰\t西酞普兰\t5- 羟色胺综合征\t参见说明书\t药效学的相互作用\t谨慎合用\n司来吉兰\t氟西汀\t高 / 低血压、昏迷等\t参见说明书：合用可产生严重反应，如共济失调、震颤、高热、 高 / 低血压、惊厥、心悸、流汗、脸红、谵妄及昏迷\t不详\t避免同时合用\n司来吉兰\t舍曲林\t高 / 低血压、昏迷等\t参见说明书：合用可产生严重反应，如共济失调、震颤、高热、 高 / 低血压、惊厥、心悸、流汗、脸红、谵妄及昏迷\t不详\t避免同时合用\n司来吉兰\t帕罗西汀\t高 / 低血压、昏迷等\t参见说明书：合用可产生严重反应，如共济失调、震颤、高热、 高 / 低血压、惊厥、心悸、流汗、脸红、谵妄及昏迷\t不详\t避免同时合用\n\n\n\n\n·3540 · http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn\n\n\nCYP3A4 代谢，与 CYP3A4 强抑制剂（ 如泊沙康唑、伏  立康唑、红霉素、克拉霉素等）合用显著减慢其代谢，\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>NSAID<|>ORGANIZATION<|>Non-Steroidal Anti-Inflammatory Drugs that inhibit COX and reduce cardiovascular protection while increasing gastrointestinal ulcer bleeding risk>  \n##  \n(\"entity\"<|>阿司匹林<|>ORGANIZATION<|>Aspirin, a medication that inhibits COX and may interact with other drugs like methotrexate and NSAIDs>  \n##  \n(\"entity\"<|>甲氨蝶呤<|>ORGANIZATION<|>Methotrexate, a drug whose blood concentration increases when used with aspirin, particularly at high doses>  \n##  \n(\"entity\"<|>氯吡格雷<|>ORGANIZATION<|>Clopidogrel, an antiplatelet drug whose efficacy is reduced when used with omeprazole or esomeprazole due to CYP2C19 competition>  \n##  \n(\"entity\"<|>奥美拉唑<|>ORGANIZATION<|>Omeprazole, a proton pump inhibitor that competes with clopidogrel for CYP2C19 metabolism, reducing clopidogrel's effectiveness>  \n##  \n(\"entity\"<|>艾司奥美拉唑<|>ORGANIZATION<|>Esomeprazole, a proton pump inhibitor that similarly competes with clopidogrel for CYP2C19 metabolism>  \n##  \n(\"entity\"<|>雷贝拉唑<|>ORGANIZATION<|>Rabeprazole, a proton pump inhibitor with minimal impact on clopidogrel's active metabolite AUC>  \n##  \n(\"entity\"<|>司来吉兰<|>ORGANIZATION<|>Selegiline, a Parkinson's disease medication that can cause severe interactions with certain antidepressants>  \n##  \n(\"entity\"<|>西酞普兰<|>ORGANIZATION<|>Citalopram, an antidepressant that can cause serotonin syndrome when combined with selegiline>  \n##  \n(\"entity\"<|>氟西汀<|>ORGANIZATION<|>Fluoxetine, an antidepressant that can cause severe reactions like hypertension, coma, and ataxia when combined with selegiline>  \n##  \n(\"entity\"<|>舍曲林<|>ORGANIZATION<|>Sertraline, an antidepressant that can cause severe reactions when combined with selegiline>  \n##  \n(\"entity\"<|>帕罗西汀<|>ORGANIZATION<|>Paroxetine, an antidepressant that can cause severe reactions when combined with selegiline>  \n##  \n(\"relationship\"<|>阿司匹林<|>甲氨蝶呤<|>Aspirin increases methotrexate blood concentration, particularly at high doses, due to competition for renal excretion<|>7>  \n##  \n(\"relationship\"<|>氯吡格雷<|>奥美拉唑<|>Omeprazole reduces clopidogrel's efficacy by competing for CYP2C19 metabolism<|>8>  \n##  \n(\"relationship\"<|>氯吡格雷<|>艾司奥美拉唑<|>Esomeprazole reduces clopidogrel's efficacy by competing for CYP2C19 metabolism<|>8>  \n##  \n(\"relationship\"<|>氯吡格雷<|>雷贝拉唑<|>Rabeprazole has minimal impact on clopidogrel's active metabolite AUC, making it a safer co-administration option<|>4>  \n##  \n(\"relationship\"<|>司来吉兰<|>西酞普兰<|>Combining selegiline with citalopram can lead to serotonin syndrome due to pharmacodynamic interactions<|>7>  \n##  \n(\"relationship\"<|>司来吉兰<|>氟西汀<|>Combining selegiline with fluoxetine can cause severe reactions like hypertension, coma, and ataxia<|>9>  \n##  \n(\"relationship\"<|>司来吉兰<|>舍曲林<|>Combining selegiline with sertraline can cause severe reactions like hypertension, coma, and ataxia<|>9>  \n##  \n(\"relationship\"<|>司来吉兰<|>帕罗西汀<|>Combining selegiline with paroxetine can cause severe reactions like hypertension, coma, and ataxia<|>9>  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_e90779ff4a684d27ead7c70bfbfd5442b1fd83f50c0bad54ec8bd1c026e49bca_v2"}